Utilize the web fullyThanks to cookies, browsing the web will be easier and more comfortable. To process some of them, we need your consent which you can give by clicking the “Accept all” button. More information about cookies and their settings. By refusing, only essential cookies will be loaded.
Accept all Refuse
Show cookie utilization selection

UO > About > Organizational Structure > Faculties & Institutes > Faculty of Medicine > Departments & Centres > Department of Hematooncology

Roman Hájek

Roman Hájek

Academic degree, name, surname:
prof. MUDr. Roman Hájek, CSc.
Room, floor, building:
R 204, Building R
Position:
Head of Department
Research interests and teaching:
Department (Faculty):
Department of Haematooncology (Faculty of Medicine)
Medical Research Center (Faculty of Medicine)
Phone number, mobile:
+420 597 372 091
E-mail:

Another education, courses

2006
Prof. – Masaryk University, Brno, Czech Republic; Field of Study: Clinical Oncology
2001
Assoc Prof. – Department of Internal Medicine and Hemato-oncology, Masaryk University Hospital Brno, Czech Republic; Field of Study: Internal Medicine
1995
Ph.D. – Department of Internal Medicine and Hemato-oncology, Masaryk University Hospital Brno, Czech Republic; Field of Study: Hematooncology
1988
M.D. – Masaryk University, Brno, Czech Republic; Field of Study: General Medicine
 

Working Practice

Since 2015
Vice-Rector for Strategy and Development; University of Ostrava, Czech Republic
Since 2012
Head of Department of Clinical Hematooncology; University Hospital Ostrava, Czech Republic
2012 – 2014
Vice-dean for Science and Research; Faculty of Medicine, Ostrava University, Czech Republic
2011 – 2015
Project manager of Babak Myeloma Group; Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
2010 – 2011
Director of Babak Research Institute; Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
2007 – 2012
Vice-Director for Education and Research; University Hospital Brno, Brno, Czech Republic
Since 1999
Head of Laboratory of Experimental Hematology and Cell Immunotherapy; University Hospital Brno, Brno, Czech Republic
1989 – 2012
Physician; Department of Internal Medicine Hematooncology, University Hospital Brno, Brno, Czech Republic
 

Valuation

IMF Brian D. Novis research grant funded through the Black Swan Research Initiative
 

Membership

Since 2012
International Myeloma Society
Since 2009
European Hematology Association
Since 2008
International Myeloma Working Group
Since 2008
American Society of Hematology
Since 2007
Scientific Advisory Board of the International Myeloma Foundation
Since 2007
European Myeloma Network (Member of the Board since 2019)
Since 2005
Medical Advisory Board of Myeloma Euronet
Since 2001
Czech Myeloma Group Foundation, Chairman
Since 1996
Czech Myeloma Group, Chairman
Since 1994
Czech Society of Hematology and Oncology (Head of Myeloma Committee since 2006)
 

Research and professional experience

2001
Royal Prince Alfred Hospital of Hematooncology – Sydney, Austrálie
1998
Arkansas Myeloma Research Center, USA
1997
Arkansas Myeloma Research Center, USA
1996
ESO course Molecular Biology for Clinicians; Cambridge, United Kingdom
1995
Georgetown University Medical Center, WA, D. C., USA
 




No record found. Database Maintenance.

View all publications



No record found. Database Maintenance.



Saving lives through research in early cancer detection and prevention: Molecular, genomic and societal factors
Period
1/2024 – 6/2028
Provider
OP JAK (Jan Amos Komenský)
State
solved
Role in the project
Principal Investigator
Total costs
48 179 516,18 CZK
 
Life Environment Research Center Ostrava
Period
1/2021 – 12/2027
Provider
Děkanát LF, Děkanát PdF, Děkanát PřF, OP ST (Spravedlivá transformace)
State
solved
Role in the project
Principal Investigator
Total costs
1 847 321 927,53 CZK
 
A novel local therapy for myeloma bone disease
Period
5/2021 – 12/2024
Provider
Ministerstvo zdravotnictví
State
finished
Role in the project
Principal Investigator
Total costs
12 448 000 CZK
 
Předprojektová příprava LERCO
Period
4/2022 – 9/2023
Provider
Lékařská fakulta, Pedagogická fakulta, Přírodovědecká fakulta, Nezařazené projekty
State
finished
Role in the project
Principal Investigator
 
WE ARE "OSTRAVSKÁ" = THE MODERN, INSPIRATIONAL AND ATTRACTIVE PLACE FOR QUALITY STUDY
Period
5/2017 – 6/2023
Provider
Rektorát, Operační program Výzkum, vývoj a vzdělávání (OP VVV)
State
finished
Role in the project
Principal Investigator
Total costs
140 003 878,92 CZK
 
Molecular, cellular and clinical approach to healthy ageing
Period
9/2018 – 6/2023
Provider
Operační program Výzkum, vývoj a vzdělávání (OP VVV)
State
in sustainability
Role in the project
Principal Investigator
Total costs
688 621 156 CZK
 
New Directions of Biomedical Research in the Ostrava Region
Period
5/2019 – 12/2022
Provider
Děkanát LF, Operační program Výzkum, vývoj a vzdělávání (OP VVV)
State
in sustainability
Role in the project
Principal Investigator
Total costs
18 399 976 CZK
 
Identification and functional validation of mutations in multiple myeloma patients resistant to therapy with proteasomal inhibitors
Period
1/2018 – 12/2020
Provider
Katedra interních oborů, MŠMT
State
finished
Role in the project
Co-Investigator
Total costs
2 028 000 CZK
 
Aberrant plasma cells clonal diversification in immunoglobulin light chain amyloidosis
Period
5/2015 – 12/2019
Provider
IGA MZd
State
finished
Role in the project
Principal Investigator
Total costs
8 582 000 CZK
 
PRO-Ost
Period
1/2017 – 10/2019
Provider
Centrum excelence IT4Innovations, divize, Děkanát FSS, Děkanát FU, Děkanát LF, Děkanát PdF, Děkanát PřF, Rektorát, Univerzitní knihovna, Operační program Výzkum, vývoj a vzdělávání (OP VVV)
State
finished
Role in the project
Principal Investigator
 
Genomic profile of aberrant plasma cells in patients with multiple myeloma in state of minimal residual disease
Period
1/2017 – 12/2018
Provider
Specifický VŠ výzkum
State
finished
Role in the project
Co-Investigator
Total costs
517 000 CZK
 
Bone Marrow Microenvironment in Multiple Myeloma: Application of 2D and 3D in vitro models using patient's specific IPSCs derived Mesenchymal Stem cells
Period
8/2016 – 12/2017
Provider
Katedra interních oborů, Projekty podporované z rozpočtu měst krajských úřadů
State
finished
Role in the project
Principal Investigator
Total costs
577 777 CZK
 
Podpora přípravy klíčových projektů OU v operačních programech EU pro nové programovací období
Period
1/2015 – 12/2015
Provider
Rozvojové programy MŠMT
State
finished
Role in the project
Principal Investigator
Total costs
1 613 000 CZK
 
Screening of mutational states of hereditary amyloidosis in the Czech Republic
Period
1/2014 – 12/2015
Provider
Specifický VŠ výzkum
State
finished
Role in the project
Co-Investigator
Total costs
270 000 CZK
 
Zahájení dlouhodobého výzkumu u monoklonálních gamapatií
Period
12/2014 – 12/2015
Provider
Lékařská fakulta, Projekty podporované z rozpočtu měst krajských úřadů
State
finished
Role in the project
Principal Investigator
Total costs
1 415 000 CZK
 
Zavedení metody sekvenování nové generace (next generation sequencing) v rámci screeningu hereditárních amyloidóz v České republice/ Dotační titul 2
Period
9/2014 – 8/2015
Provider
Lékařská fakulta, Přírodovědecká fakulta, Projekty podporované z rozpočtu měst krajských úřadů
State
finished
Role in the project
Principal Investigator
Total costs
788 500 CZK
 
Dynamics of microRNA and cellfree DNA profiles during multiple myeloma progression
Period
1/2014 – 12/2014
Provider
Ostatní projekty ze zahr. prostředků
State
finished
Role in the project
Principal Investigator
Total costs
55 538 EUR
 
Zavedení a využití metody separace jednotlivých buněk pomocí imunofluorescenčních metod a následné aplikace v hematoonkologii
Period
10/2013 – 12/2014
Provider
Lékařská fakulta, Projekty podporované z rozpočtu měst krajských úřadů
State
finished
Role in the project
Principal Investigator
Total costs
2 249 400 CZK
 

Instagram
RSS
social hub